Health systems worldwide face a range of significant challenges, including growing ageing populations needing more care, increasing chronic disease burdens, medical workforce shortages and mounting healthcare costs.
Meanwhile, patients and consumers increasingly expect more digital, personalised experiences across their end-to-end healthcare journeys, which necessitates innovation and investment despite financial pressures.
In response, many health systems are accelerating their focus on digital transformation to enhance patient outcomes and build more resilient and sustainable healthcare models, as can be seen in the case of Taiwan.
Health innovation in Taiwan
Taiwan’s health system has been widely praised for its universal coverage, efficiency and affordability, but it is having to shift from a treatment- to a prevention-focused model to better cope with a super-ageing society.
Precision health is key to this new healthcare direction, with the government designating it a priority area for support regarding the development and commercialisation of new personalised treatments and technologies.
Another related focus is digital healthcare and the integration of smart technologies like AI and IoT to create a more connected and efficient care ecosystem, which is underpinned by growing cross-sector collaborations.
Helping you navigate the market
These developments are attracting growing interest from international healthcare and biomedical businesses in Taiwan’s health industries market and the potential opportunities for growth, investment and collaboration.
Accordingly, PwC has produced this introductory guide for those interested to understand more about Taiwan’s healthcare system and its core biomedical sectors of biotechnology, pharmaceuticals and medical devices.
We hope you find the guide useful. Please do not hesitate to contact us if you would like further information or have questions about Taiwan’s health industries and how PwC can be of help.
Contact us
